Oragenics Inc (OGEN)
0.42
+0.02
(+5.05%)
USD |
NYAM |
Oct 04, 16:00
0.4143
-0.01
(-1.36%)
Pre-Market: 20:00
Oragenics Shareholders Equity (Annual): 3.168M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 3.168M |
December 31, 2022 | 13.01M |
December 31, 2021 | 26.49M |
December 31, 2020 | 16.84M |
December 31, 2019 | 17.23M |
December 31, 2018 | 20.88M |
December 31, 2017 | 6.316M |
December 31, 2016 | 2.966M |
December 31, 2015 | 4.731M |
December 31, 2014 | 10.34M |
December 31, 2013 | 15.84M |
Date | Value |
---|---|
December 31, 2012 | 9.232M |
December 31, 2011 | -8.179M |
December 31, 2010 | -1.899M |
December 31, 2009 | 2.640M |
December 31, 2008 | -0.1772M |
December 31, 2007 | 0.8199M |
December 31, 2006 | 1.278M |
December 31, 2005 | 1.772M |
December 31, 2004 | 4.036M |
December 31, 2003 | 3.440M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
3.168M
Minimum
2023
26.49M
Maximum
2021
15.35M
Average
16.84M
Median
2020
Shareholders Equity (Annual) Benchmarks
Shuttle Pharmaceuticals Holdings Inc | 4.056M |
Perspective Therapeutics Inc | 75.18M |
Alaunos Therapeutics Inc | 6.307M |
Cocrystal Pharma Inc | 26.38M |
Cara Therapeutics Inc | 57.08M |